Cohort Study of Pioglitazone and Bladder Cancer in Patients With Diabetes
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2016
At a glance
- Drugs Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Takeda
- 09 Sep 2014 Status changed from active, no longer recruiting to completed.
- 28 Aug 2014 Final 10-year results published in the Media Release.
- 31 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.